Page last updated: 2024-09-02

perindopril and Coronary Restenosis

perindopril has been researched along with Coronary Restenosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SoRelle, R1
Abe, Y; Hirosaka, A; Hisa, S; Igarashi, M; Kijima, M; Komatsu, N; Maehara, K; Maruyama, Y; Mitsugi, M; Ohwada, T; Tsuda, T; Ujiie, Y; Yaoita, H1

Trials

1 trial(s) available for perindopril and Coronary Restenosis

ArticleYear
Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis.
    International heart journal, 2006, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cilostazol; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Perindopril; Platelet Aggregation Inhibitors; Quinapril; Stents; Tetrahydroisoquinolines; Tetrazoles

2006

Other Studies

1 other study(ies) available for perindopril and Coronary Restenosis

ArticleYear
Stenosis and the drug-eluting stent.
    Circulation, 2004, Mar-23, Volume: 109, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Azetidines; Cardiology; Coronary Restenosis; Diabetes Complications; Ezetimibe; Humans; Hypercholesterolemia; Myocardial Infarction; Myocardial Ischemia; Perindopril; Radionuclide Imaging; Randomized Controlled Trials as Topic; Stents

2004